Biggest News Aggregation in the World
📰 Import Authorization News

Import Authorization News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Import Authorization. Real-time updates on events, politics, business and more.

DGAP-News: XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips

DGAP-News: XPhyto Therapeutics Corp. / Key word(s): Miscellaneous XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips 15.12.2021 / 09:05 The issuer is solely responsible for the content of this announcement. XPhyto Epilep...
United States Baden Wüberg British Columbia Hugh Rogers Knox Henderson Distribution Services

XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / December 15, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide an update on the development
United States Baden Wüberg British Columbia Hugh Rogers Knox Henderson Clinical Research Center

XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips

15.12.2021 - VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / December 15, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (XPhyto or the Company) is pleased to provide an update on the development of its fast-dissolving CBD oral ... Seite 1
Global Market Insights Inc Product Development Transparency Market Research European Medicines Agency Us Food Drug Administration Clinical Research Center

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science